دورية أكاديمية

The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials.

التفاصيل البيبلوغرافية
العنوان: The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials.
المؤلفون: Fieldhouse, Jay L. P., van Paassen, Dirk N., van Engelen, Marie-Paule E., De Boer, Sterre C. M., Hartog, Willem L., Braak, Simon, Schoonmade, Linda J., Schouws, Sigfried N. T. M., Krudop, Welmoed A., Oudega, Mardien L., Mutsaerts, Henk J. M. M., Teunissen, Charlotte E., Vijverberg, Everard G. B., Pijnenburg, Yolande A. L.
المصدر: Frontiers in Aging Neuroscience; 2024, p1-14, 14p
مصطلحات موضوعية: GLUCOSE metabolism, MEDICAL information storage & retrieval systems, BEHAVIOR disorders, DIAGNOSTIC imaging, RESEARCH funding, FUNCTIONAL connectivity, SINGLE-photon emission computed tomography, FUNCTIONAL assessment, FRONTOTEMPORAL dementia, SOCIAL perception, MAGNETIC resonance imaging, POSITRON emission tomography, SYSTEMATIC reviews, MEDLINE, ATROPHY, SERUM, LITERATURE reviews, BLOOD plasma, ONLINE information services, CEREBRAL circulation, SENILE dementia, BIOMARKERS, DISEASE progression, COGNITION, PSYCHOSOCIAL functioning, CEREBROSPINAL fluid
مستخلص: Behavioral variant frontotemporal dementia (bvFTD) is a neurodegenerative disorder characterized by diverse and prominent changes in behavior and personality. One of the greatest challenges in bvFTD is to capture, measure and predict its disease progression, due to clinical, pathological and genetic heterogeneity. Availability of reliable outcome measures is pivotal for future clinical trials and disease monitoring. Detection of change should be objective, clinically meaningful and easily assessed, preferably associated with a biological process. The purpose of this scoping review is to examine the status of longitudinal studies in bvFTD, evaluate current assessment tools and propose potential progression markers. A systematic literature search (in PubMed and Embase.com) was performed. Literature on disease trajectories and longitudinal validity of frequently-used measures was organized in five domains: global functioning, behavior, (social) cognition, neuroimaging and fluid biomarkers. Evaluating current longitudinal data, we propose an adaptive battery, combining a set of sensitive clinical, neuroimaging and fluid markers, adjusted for genetic and sporadic variants, for adequate detection of disease progression in bvFTD. [ABSTRACT FROM AUTHOR]
Copyright of Frontiers in Aging Neuroscience is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:16634365
DOI:10.3389/fnagi.2024.1382593